| |
| |
|
| Insider
Information: |
Walbert Timothy P |
| Relationship: |
Director |
| City: |
Waukegan |
| State: |
IL |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
131,514 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$3,346,734 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
131,514 |
|
|
| Total
Value |
$3,346,734 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Horizon Pharma, Inc. |
HZNP |
Chairman, President an... |
2023-10-06 |
0 |
2023-10-06 |
0 |
Premium* |
|
|
XOMA Corporation |
XOMA |
Director |
2016-07-21 |
129,314 |
2012-11-13 |
0 |
Premium* |
|
|
Egalet Corp |
EGLT |
Director |
2020-05-20 |
0 |
|
0 |
Premium* |
|
|
Sucampo Pharmaceuticals, Inc. |
SCMP |
Director |
2018-02-13 |
0 |
2016-06-02 |
0 |
Premium* |
|
|
Sagimet Biosciences Inc. |
SGMT |
Director |
2024-04-01 |
2,200 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
160 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 7
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2020-02-19 |
4 |
D |
$36.06 |
$773,739 |
D/D |
(21,457) |
941,607 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2020-02-21 |
4 |
AS |
$35.23 |
$3,306,829 |
D/D |
(93,864) |
847,743 |
0 |
- |
|
| EGLT |
Egalet Corp |
Director |
– • – |
2020-03-04 |
4 |
A |
$0.00 |
$0 |
D/D |
13,620 |
13,620 |
0 |
- |
|
| EGLT |
Egalet Corp |
Director |
– • – |
2020-04-23 |
4 |
OE |
$1.75 |
$11,667 |
D/D |
6,667 |
6,667 |
0 |
- |
|
| EGLT |
Egalet Corp |
Director |
– • – |
2020-04-23 |
4 |
D |
$1.75 |
$1,666 |
D/D |
(952) |
5,715 |
0 |
- |
|
| EGLT |
Egalet Corp |
Director |
– • – |
2020-04-23 |
4/A |
D |
$1.75 |
$3,159 |
D/D |
(1,805) |
4,862 |
0 |
- |
|
| EGLT |
Egalet Corp |
Director |
– • – |
2020-05-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(26,953) |
0 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2020-05-21 |
4 |
GD |
$0.00 |
$0 |
D/D |
5,000 |
843,792 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2020-08-06 |
4 |
AS |
$70.76 |
$7,979,414 |
D/D |
(110,000) |
733,792 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2021-01-05 |
4 |
D |
$73.28 |
$117,028 |
I/I |
(1,597) |
11,988 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2021-01-05 |
4 |
OE |
$0.00 |
$0 |
I/I |
3,386 |
13,585 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2021-01-05 |
4 |
D |
$73.28 |
$24,723,206 |
D/D |
(337,380) |
1,157,763 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2021-01-05 |
4 |
A |
$0.00 |
$0 |
D/D |
492,294 |
1,495,143 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2021-01-05 |
4 |
OE |
$0.00 |
$0 |
D/D |
269,057 |
1,002,849 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2021-01-15 |
4 |
AS |
$77.26 |
$16,449,893 |
D/D |
(211,204) |
946,559 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2021-01-21 |
4 |
OE |
$0.00 |
$0 |
D/D |
20,330 |
966,889 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2021-01-21 |
4 |
D |
$77.43 |
$697,412 |
D/D |
(9,007) |
957,882 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2021-01-21 |
4 |
OE |
$0.00 |
$0 |
I/I |
2,575 |
14,563 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2021-01-21 |
4 |
D |
$77.43 |
$58,460 |
I/I |
(755) |
13,808 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2021-01-22 |
4 |
AS |
$76.25 |
$865,917 |
D/D |
(11,323) |
946,559 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2021-02-01 |
4 |
D |
$77.04 |
$227,268 |
I/I |
(2,950) |
19,945 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2021-02-01 |
4 |
OE |
$0.00 |
$0 |
I/I |
9,087 |
22,895 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2021-02-17 |
4 |
A |
$0.00 |
$0 |
D/D |
9,433 |
955,992 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2021-02-17 |
4 |
D |
$87.17 |
$364,283 |
D/D |
(4,179) |
951,813 |
0 |
- |
|
| HZNP |
Horizon Pharma, Inc. |
Chairman, President and CEO |
• • – |
2021-03-01 |
4 |
AS |
$91.29 |
$2,464,137 |
D/D |
(26,975) |
924,838 |
0 |
- |
|
160 Records found
|
|
Page 4 of 7 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
